Identification is a vital part of the non-targeted screening data interpretation during a chemical characterization study of a medical device. A correct identification is a key element for the toxicological assessment since the toxic potential of a compound is directly linked to its chemical structure. Assigning a wrong identity inevitably leads to a flawed toxicological assessment where, in a worst-case scenario, the safety of the patient may be at risk. Adherence to good identification practices should mitigate the risk of securing incorrect identifications. In this presentation our suggested good identification practices will be explained in more detail. Additionally, strategies to upgrade the identification level of reported compounds will be discussed

Presenter: Ward D’Autry PhD, Senior E&L Expert Nelson Labs Europe